Skip to search formSkip to main contentSkip to account menu

octreotide pamoate

Known as: OP LAR, Octreotide Embpnate, Octreotide Pamoate LAR(SMS 201-995) 
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and… 
Highly Cited
2004
Highly Cited
2004
OBJECTIVE High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with… 
Highly Cited
2002
Highly Cited
2002
PURPOSE The purpose of this research was to determine whether insulin-like growth factor (IGF) suppression, using a long-acting… 
2002
2002
Long‐acting release octreotide pamoate (OP‐LAR) is a synthetic octapeptide that can be administered monthly and whose activity is… 
1998
1998
Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment…